WHO/HAI antibiotic pricing data for treatment of neonatal sepsis by WHO region.

Total cost is estimated for the course of treating a 3 kg neonatal child for 10 days. For capsular formulation, the assumption was reconstitution in sterile water. For oral suspension 10% wastage was assumed.For vials, a shelf life of 24 hours was assumed for ceftriaxone. The data were from 2001 to 2013, and were not adjusted for inflation.aData based on national surveys from: AFR (n = 4), AMR (n = 1).bData based on national surveys from: AFR (n = 8), AMR (n = 2), EMR (n = 9), SEAR (n = 4), WPR (n = 5).cData based on national surveys from: AFR (n = 15), AMR (n = 9), EMR (n = 13), SEAR (n = 4), WPR (n = 5).dData based on national surveys from: AFR (n = 15), AMR (n = 9), EMR (n = 13), SEAR (n = 3), WPR (n = 4).eData based on national surveys from: AFR (n = 0), AMR (n = 1), EMR (n = 0), SEAR (n = 0), WPR (n = 0).AFR, Africa; AMR, Americas; EMR, Eastern Mediterranean; SEAR, Southeast Asia; WPR, Western Pacific.WHO/HAI antibiotic pricing data for treatment of neonatal sepsis by WHO region.